Anorexia Nervosa Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
The global anorexia nervosa market size was estimated to be US$ 90 million in 2021 and is expected grow at a CAGR of 15% between 2023 to 2032.
Anorexia nervosa is characterized as a dietary/eating disorder expressed by the fear of putting on weight and misplaced view of body weight. Individuals suffering from this disorder have irregular body weight, severe anorexia and they go to extreme lengths to control their weight and shape. Such unusual tendencies fundamentally disrupt the everyday activities and drastically limit the amount of daily nutrition. Individuals may control calories by purposely vomiting after eating or by abusing laxatives. Some individuals struggle to get fit by exercising excessively.
Symptoms of anorexia nervosa are:
- Thin appearance
- Irregular blood counts
- Discoloration of the fingers
- Hair fall
- Irregular of menstruation cycle
- Weight loss
The fundamental objective in treatment of anorexia nervosa is to regularize eating patterns and incorporate practices that help gain weight. The secondary objective is to change distorted convictions and beliefs that support restricted eating behavior. Therefore, continuous treatment and sustenance instruction are crucial aspects of overall recovery. Treatments for dietary disorders utilize a group approach for psychotherapy. This approach includes medical care providers like dietitians or doctors, psychological wellness providers and also incorporates hospitalization.
Increasing frequency of dietary disorders
Anorexia nervosa is the third most chronic condition affecting young adults globally. As a result, the markets are likely to see a steady demand of treatment opportunities for clinics, homecare and hospitals. Psychologists, specialist counsellors, psychiatrists, dietitians, specialist nurses, nutritionists, and pediatricians in cases affecting kids and teenagers are involved in the growth of this market globally.
Awareness about dietary disorders
Awareness about restrictive eating behavior patterns, greater healthcare literacy in emerging nations and awareness about overall anorexia nervosa treatment is driving the global markets towards a steady growth during the forthcoming years. Various lifestyle factors including smoking, hereditary disorders, hypertension, and extreme exercise are also critical components for driving the global anorexia nervosa treatment market.
Lack of awareness and stigmatization
One of the major challenges for this market is the patient’s social stigma and unwillingness to accept their situation. Furthermore, most of the current treatment options are focused on non-pharmacological therapies including the clinical recommendations and guidelines, thus impeding the growth of anorexia nervosa market. Moreover, there is also a scarcity of trainers and experts to talk with patients and spread awareness among the population.
The key players in anorexia nervosa market are EDH, Timberlines Knolls, Eating Disorders Victoria, NEDC, National Association of Anorexia Nervosa and others.
The anorexia nervosa market can be segmented into:
By Psychological Therapy:
- Individual therapy (insight-oriented)
- Cognitive analytic therapy
- Cognitive behavioral therapy (CBT)
- Family-based therapy (FBT)
- Specialist supportive clinical management (SSCM)
- Pharmacologic Therapy
- Others (Medications and Supplementary Diet via Counselling)
By End User:
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Rest of South America